Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Stress signaling etches heritable marks on chromatin.
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.
ATX-MS-1467, An Immunotolerizing Agent, Halts Disease Progression and Reduces CNS Inflammation in Rodent Models of Multiple Sclerosis (P1.216)
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
Rare variants in the CYP27B1 gene are associated with multiple sclerosis.
Lipocalin 2 is present in the EAE brain and is modulated by natalizumab.
Shorter washout reduces MS relapse switching off natalizumab
Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1R ) and receptor-5 (S1P5R ) agonist with autoimmune disease-modifying activity.
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects.
Motor skill learning requires active central myelination.
Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case--control ultrasound study.

Pages